Thierry Lomberget

6PUBLICATIONS
26CO-AUTHORS
Cheminformatics and quantitative structure-activity relationshipsMedical devicesPredictive and prognostic markersBiologically active molecules
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Oct 21, 2024
Design, synthesis, and structure-activity relationship studies of 6<i>H</i>-benzo[<i>b</i>]indeno[1,2-<i>d</i>]thiophen-6-one derivatives as DYRK1A/CLK1/CLK4/haspin inhibitors.

Abdelfattah Faouzi, Alexandre Arnaud, François Hallé

|Aug 31, 2022
Pharmacomodulation of a ligand targeting the HBV capsid hydrophobic pocket.

Mathilde Briday, François Hallé, Lauriane Lecoq

|Jun 17, 2020
Fragment Linking Strategies for Structure-Based Drug Design.

Alexandre Bancet, Claire Raingeval, Thierry Lomberget

|Feb 20, 2019
In vitro modulation of multidrug resistance by pregnane steroids and in vivo inhibition of tumour development by 7α-OBz-11α(R)-OTHP-5β-pregnanedione in K562/R7 and H295R cell xenografts.

Ghina Alameh, Agnès Emptoz-Bonneton, Marc Rolland de Ravel

|Jan 29, 2019
2-Aminothiazole Derivatives as Selective Allosteric Modulators of the Protein Kinase CK2. 1. Identification of an Allosteric Binding Site.

Benoît Bestgen, Isabelle Krimm, Irina Kufareva

|Jan 29, 2019
2-Aminothiazole Derivatives as Selective Allosteric Modulators of the Protein Kinase CK2. 2. Structure-Based Optimization and Investigation of Effects Specific to the Allosteric Mode of Action.

Benoît Bestgen, Irina Kufareva, Weiguang Seetoh

Pageof 1

Frequent Collaborators

5 joint publications

Marc Le Borgne

3 joint publications

Matthias Engel

2 joint publications

Weiguang Seetoh

2 joint publications

Chris Abell